$HUN
Huntsman CORP

2020 Q1 Form 10-Q Financial Statement

#000155837020004917 Filed on May 01, 2020

View on sec.gov

Income Statement

Concept 2020 Q1 2019 Q1
Revenue $1.593B $1.669B
YoY Change -4.55% -9.19%
Cost Of Revenue $1.296B $1.310B
YoY Change -1.07% -25.36%
Gross Profit $297.0M $359.0M
YoY Change -17.27% -22.96%
Gross Profit Margin 18.64% 21.51%
Selling, General & Admin $199.0M $207.0M
YoY Change -3.86% 7.81%
% of Gross Profit 67.0% 57.66%
Research & Development $36.00M $36.00M
YoY Change 0.0% -5.26%
% of Gross Profit 12.12% 10.03%
Depreciation & Amortization $67.00M $67.00M
YoY Change 0.0% -18.29%
% of Gross Profit 22.56% 18.66%
Operating Expenses $243.0M $244.0M
YoY Change -0.41% 0.83%
Operating Profit $54.00M $115.0M
YoY Change -53.04% -48.66%
Interest Expense -$18.00M -$30.00M
YoY Change -40.0% 114.29%
% of Operating Profit -33.33% -26.09%
Other Income/Expense, Net $10.00M $5.000M
YoY Change 100.0% -28.57%
Pretax Income -$62.00M $153.0M
YoY Change -140.52% -47.06%
Income Tax $7.000M $45.00M
% Of Pretax Income 29.41%
Net Earnings $705.0M $119.0M
YoY Change 492.44% -56.57%
Net Earnings / Revenue 44.26% 7.13%
Basic Earnings Per Share $3.16 $0.51
Diluted Earnings Per Share $3.16 $0.51
COMMON SHARES
Basic Shares Outstanding 223.2M 233.1M
Diluted Shares Outstanding 223.2M 235.1M

Balance Sheet

Concept 2020 Q1 2019 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.594B $444.0M
YoY Change 259.01% 0.0%
Cash & Equivalents $1.594B $444.0M
Short-Term Investments
Other Short-Term Assets $145.0M $110.0M
YoY Change 31.82% -96.7%
Inventory $1.008B $1.228B
Prepaid Expenses
Receivables $1.013B $1.276B
Other Receivables $14.00M $10.00M
Total Short-Term Assets $3.774B $3.136B
YoY Change 20.34% -50.88%
LONG-TERM ASSETS
Property, Plant & Equipment $2.357B $3.055B
YoY Change -22.85% -1.99%
Goodwill $396.0M
YoY Change
Intangibles $351.0M $215.0M
YoY Change 63.26%
Long-Term Investments $426.0M $612.0M
YoY Change -30.39% 115.49%
Other Assets $453.0M $566.0M
YoY Change -19.96% -21.5%
Total Long-Term Assets $4.684B $5.504B
YoY Change -14.9% 27.47%
TOTAL ASSETS
Total Short-Term Assets $3.774B $3.136B
Total Long-Term Assets $4.684B $5.504B
Total Assets $8.458B $8.640B
YoY Change -2.11% -19.27%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $825.0M $881.0M
YoY Change -6.36% -11.28%
Accrued Expenses $739.0M $476.0M
YoY Change 55.25% -10.69%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $134.0M $276.0M
YoY Change -51.45% 666.67%
Total Short-Term Liabilities $1.774B $1.718B
YoY Change 3.26% -47.67%
LONG-TERM LIABILITIES
Long-Term Debt $2.049B $2.323B
YoY Change -11.8% 1.09%
Other Long-Term Liabilities $833.0M $1.027B
YoY Change -18.89% -5.26%
Total Long-Term Liabilities $2.882B $1.027B
YoY Change 180.62% -69.63%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.774B $1.718B
Total Long-Term Liabilities $2.882B $1.027B
Total Liabilities $5.075B $6.054B
YoY Change -16.17% -23.49%
SHAREHOLDERS EQUITY
Retained Earnings $1.350B
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $3.243B $2.586B
YoY Change
Total Liabilities & Shareholders Equity $8.458B $8.640B
YoY Change -2.11% -19.27%

Cashflow Statement

Concept 2020 Q1 2019 Q1
OPERATING ACTIVITIES
Net Income $705.0M $119.0M
YoY Change 492.44% -56.57%
Depreciation, Depletion And Amortization $67.00M $67.00M
YoY Change 0.0% -18.29%
Cash From Operating Activities -$75.00M -$31.00M
YoY Change 141.94% -119.02%
INVESTING ACTIVITIES
Capital Expenditures $61.00M $61.00M
YoY Change 0.0% -210.91%
Acquisitions $346.0M
YoY Change
Other Investing Activities -$3.000M $16.00M
YoY Change -118.75% -119.75%
Cash From Investing Activities $1.511B -$54.00M
YoY Change -2898.15% -60.29%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $96.00M $32.00M
YoY Change 200.0%
Debt Paid & Issued, Net $0.00 $652.0M
YoY Change -100.0%
Cash From Financing Activities -$354.0M 183.0M
YoY Change -293.44% -312.79%
NET CHANGE
Cash From Operating Activities -$75.00M -31.00M
Cash From Investing Activities $1.511B -54.00M
Cash From Financing Activities -$354.0M 183.0M
Net Change In Cash $1.069B 104.0M
YoY Change 927.88% -276.27%
FREE CASH FLOW
Cash From Operating Activities -$75.00M -$31.00M
Capital Expenditures $61.00M $61.00M
Free Cash Flow -$136.0M -$92.00M
YoY Change 47.83% -142.2%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001307954
CY2020Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2020Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
CY2020Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2020Q1 dei Amendment Flag
AmendmentFlag
false
CY2020Q1 dei Document Type
DocumentType
10-Q
CY2020Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2020Q1 dei Document Period End Date
DocumentPeriodEndDate
2020-03-31
CY2020Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2020Q1 dei Entity File Number
EntityFileNumber
001-32427
CY2020Q1 dei Entity Registrant Name
EntityRegistrantName
Huntsman Corporation
CY2020Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
10003 Woodloch Forest Drive
CY2020Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
The Woodlands
CY2020Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
CY2020Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
77380
CY2020Q1 dei City Area Code
CityAreaCode
281
CY2020Q1 dei Local Phone Number
LocalPhoneNumber
719-6000
CY2020Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2020Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
42-1648585
CY2020Q1 dei Security12b Title
Security12bTitle
Common Stock, par value $0.01 per share
CY2020Q1 dei Trading Symbol
TradingSymbol
HUN
CY2020Q1 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2020Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2020Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2020Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2020Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2020Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2020Q1 dei Entity Shell Company
EntityShellCompany
false
CY2020Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
220533935
CY2020Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1594000000
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
525000000
CY2020Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
22000000
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
19000000
CY2020Q1 us-gaap Pledged Assets Not Separately Reported Finance Receivables
PledgedAssetsNotSeparatelyReportedFinanceReceivables
252000000
CY2019Q4 us-gaap Pledged Assets Not Separately Reported Finance Receivables
PledgedAssetsNotSeparatelyReportedFinanceReceivables
221000000
CY2020Q1 us-gaap Accounts Notes And Loans Receivable Net Current
AccountsNotesAndLoansReceivableNetCurrent
1013000000
CY2019Q4 us-gaap Accounts Notes And Loans Receivable Net Current
AccountsNotesAndLoansReceivableNetCurrent
940000000
CY2020Q1 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
14000000
CY2019Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
13000000
CY2020Q1 us-gaap Inventory Net
InventoryNet
1008000000
CY2019Q4 us-gaap Inventory Net
InventoryNet
914000000
CY2020Q1 us-gaap Other Assets Current
OtherAssetsCurrent
145000000
CY2019Q4 us-gaap Other Assets Current
OtherAssetsCurrent
155000000
CY2019Q4 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
1208000000
CY2020Q1 us-gaap Assets Current
AssetsCurrent
3774000000
CY2019Q4 us-gaap Assets Current
AssetsCurrent
3755000000
CY2020Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2357000000
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2383000000
CY2020Q1 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
426000000
CY2019Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
535000000
CY2020Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
351000000
CY2019Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
197000000
CY2020Q1 us-gaap Goodwill
Goodwill
396000000
CY2019Q4 us-gaap Goodwill
Goodwill
276000000
CY2020Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
287000000
CY2019Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
292000000
CY2020Q1 us-gaap Due From Affiliate Noncurrent
DueFromAffiliateNoncurrent
34000000
CY2019Q4 us-gaap Due From Affiliate Noncurrent
DueFromAffiliateNoncurrent
34000000
CY2020Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
380000000
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
396000000
CY2020Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
453000000
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
452000000
CY2020Q1 us-gaap Assets
Assets
8458000000
CY2019Q4 us-gaap Assets
Assets
8320000000
CY2020Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
825000000
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
765000000
CY2020Q1 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
31000000
CY2019Q4 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
57000000
CY2020Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
739000000
CY2019Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
29000000
CY2020Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
365000000
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
384000000
CY2020Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
833000000
CY2019Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
898000000
CY2020Q1 us-gaap Liabilities
Liabilities
5075000000
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
420000000
CY2020Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
134000000
CY2019Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
212000000
CY2020Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
45000000
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
42000000
CY2019Q4 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
512000000
CY2020Q1 us-gaap Liabilities Current
LiabilitiesCurrent
1774000000
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2008000000
CY2020Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2049000000
CY2019Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2177000000
CY2020Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
54000000
CY2019Q4 us-gaap Liabilities
Liabilities
5496000000
CY2020Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1200000000
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1200000000
CY2020Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
258124697
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
257405496
CY2020Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
219647609
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
224295868
CY2020Q1 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
3000000
CY2019Q4 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
3000000
CY2020Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
4034000000
CY2019Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
4008000000
CY2020Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
38477091
CY2019Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
33112572
CY2020Q1 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
731000000
CY2019Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
635000000
CY2020Q1 us-gaap Deferred Compensation Equity
DeferredCompensationEquity
30000000
CY2019Q4 us-gaap Deferred Compensation Equity
DeferredCompensationEquity
17000000
CY2020Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
1350000000
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
690000000
CY2020Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1383000000
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1362000000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
3243000000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
2687000000
CY2020Q1 us-gaap Minority Interest
MinorityInterest
140000000
CY2019Q4 us-gaap Minority Interest
MinorityInterest
137000000
CY2020Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3383000000
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2824000000
CY2020Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
8458000000
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
8320000000
CY2020Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1593000000
CY2019Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1669000000
CY2020Q1 us-gaap Cost Of Revenue
CostOfRevenue
1296000000
CY2019Q1 us-gaap Cost Of Revenue
CostOfRevenue
1310000000
CY2020Q1 us-gaap Gross Profit
GrossProfit
297000000
CY2019Q1 us-gaap Gross Profit
GrossProfit
359000000
CY2020Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
199000000
CY2019Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
207000000
CY2020Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
36000000
CY2019Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
36000000
CY2020Q1 hun Restructuring Impairment And Plant Closing Costs
RestructuringImpairmentAndPlantClosingCosts
3000000
CY2019Q1 hun Restructuring Impairment And Plant Closing Costs
RestructuringImpairmentAndPlantClosingCosts
1000000
CY2020Q1 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-5000000
CY2020Q1 us-gaap Operating Expenses
OperatingExpenses
243000000
CY2019Q1 us-gaap Operating Expenses
OperatingExpenses
244000000
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
54000000
CY2019Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
115000000
CY2020Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-18000000
CY2019Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-30000000
CY2020Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
2000000
CY2019Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
10000000
CY2020Q1 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-110000000
CY2019Q1 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
76000000
CY2019Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-23000000
CY2020Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
10000000
CY2019Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
5000000
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-62000000
CY2019Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
153000000
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7000000
CY2019Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
45000000
CY2020Q1 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-69000000
CY2019Q1 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
108000000
CY2020Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
777000000
CY2019Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
23000000
CY2020Q1 us-gaap Profit Loss
ProfitLoss
708000000
CY2019Q1 us-gaap Profit Loss
ProfitLoss
131000000
CY2020Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
3000000
CY2019Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
12000000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
705000000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
119000000
CY2020Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.32
CY2019Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.41
CY2020Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
3.48
CY2019Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0.10
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.16
CY2019Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.51
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
223200000
CY2019Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
233100000
CY2020Q1 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.32
CY2019Q1 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.41
CY2020Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
3.48
CY2019Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0.10
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.16
CY2019Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.51
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
223200000
CY2019Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
235100000
CY2020Q1 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-72000000
CY2019Q1 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
96000000
CY2020Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
777000000
CY2019Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
23000000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
705000000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
119000000
CY2020Q1 us-gaap Profit Loss
ProfitLoss
708000000
CY2019Q1 us-gaap Profit Loss
ProfitLoss
131000000
CY2020Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-73000000
CY2019Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
42000000
CY2020Q1 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-52000000
CY2019Q1 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-12000000
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-21000000
CY2019Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
54000000
CY2020Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
687000000
CY2019Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
185000000
CY2020Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
3000000
CY2019Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
14000000
CY2020Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
684000000
CY2019Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
171000000
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2824000000
CY2020Q1 us-gaap Profit Loss
ProfitLoss
708000000
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-21000000
CY2020Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
4000000
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7000000
CY2020Q1 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
6000000
CY2020Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
96000000
CY2020Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.1625
CY2020Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
37000000
CY2020Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3383000000
CY2018Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2749000000
CY2019Q1 us-gaap Profit Loss
ProfitLoss
131000000
CY2019Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
54000000
CY2019Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
7000000
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6000000
CY2019Q1 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
12000000
CY2019Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1000000
CY2019Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
34000000
CY2019Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.1625
CY2019Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
39000000
CY2019Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2863000000
CY2020Q1 us-gaap Profit Loss
ProfitLoss
708000000
CY2019Q1 us-gaap Profit Loss
ProfitLoss
131000000
CY2020Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
777000000
CY2019Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
23000000
CY2020Q1 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-69000000
CY2019Q1 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
108000000
CY2020Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
2000000
CY2019Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
10000000
CY2020Q1 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-110000000
CY2019Q1 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
76000000
CY2020Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
67000000
CY2019Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
67000000
CY2019Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-23000000
CY2020Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-2000000
CY2019Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
10000000
CY2020Q1 us-gaap Share Based Compensation
ShareBasedCompensation
7000000
CY2019Q1 us-gaap Share Based Compensation
ShareBasedCompensation
8000000
CY2020Q1 hun Cash Paid For Income Taxes On Proceeds From Sale Of Business
CashPaidForIncomeTaxesOnProceedsFromSaleOfBusiness
2000000
CY2020Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-14000000
CY2019Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-13000000
CY2020Q1 us-gaap Increase Decrease In Accounts And Notes Receivable
IncreaseDecreaseInAccountsAndNotesReceivable
34000000
CY2019Q1 us-gaap Increase Decrease In Accounts And Notes Receivable
IncreaseDecreaseInAccountsAndNotesReceivable
15000000
CY2020Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
92000000
CY2019Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
82000000
CY2020Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-6000000
CY2019Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
4000000
CY2020Q1 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-1000000
CY2019Q1 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-22000000
CY2020Q1 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
7000000
CY2019Q1 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
26000000
CY2020Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
61000000
CY2019Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-10000000
CY2020Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-44000000
CY2019Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-43000000
CY2020Q1 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-54000000
CY2019Q1 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-25000000
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-40000000
CY2019Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-40000000
CY2020Q1 us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
-35000000
CY2019Q1 us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
9000000
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-75000000
CY2019Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-31000000
CY2020Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
61000000
CY2019Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
61000000
CY2020Q1 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
1915000000
CY2020Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
346000000
CY2019Q1 hun Cash Proceeds From Forward Swap Contract From Sale Of Investment
CashProceedsFromForwardSwapContractFromSaleOfInvestment
16000000
CY2020Q1 hun Proceeds From Reimbursements Of Capital Expenditures
ProceedsFromReimbursementsOfCapitalExpenditures
3000000
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
1511000000
CY2019Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-45000000
CY2019Q1 us-gaap Cash Provided By Used In Investing Activities Discontinued Operations
CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
-9000000
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
1511000000
CY2019Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-54000000
CY2020Q1 us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
-158000000
CY2019Q1 us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
211000000
CY2019Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
652000000
CY2019Q1 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
742000000
CY2020Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
32000000
CY2019Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
7000000
CY2019Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
6000000
CY2020Q1 us-gaap Payments Of Dividends Minority Interest
PaymentsOfDividendsMinorityInterest
23000000
CY2020Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
37000000
CY2019Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
39000000
CY2020Q1 hun Repurchase And Cancellation Of Stock Awards
RepurchaseAndCancellationOfStockAwards
6000000
CY2019Q1 hun Repurchase And Cancellation Of Stock Awards
RepurchaseAndCancellationOfStockAwards
12000000
CY2019Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1000000
CY2020Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
96000000
CY2019Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
33000000
CY2019Q1 us-gaap Payments Of Debt Extinguishment Costs
PaymentsOfDebtExtinguishmentCosts
21000000
CY2020Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-2000000
CY2019Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-1000000
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-354000000
CY2019Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
183000000
CY2020Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-13000000
CY2019Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6000000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1069000000
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
104000000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
525000000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
340000000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1594000000
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
444000000
CY2020Q1 us-gaap Interest Paid Net
InterestPaidNet
5000000
CY2019Q1 us-gaap Interest Paid Net
InterestPaidNet
26000000
CY2020Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
36000000
CY2019Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
14000000
CY2020Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
59000000
CY2019Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
50000000
CY2020Q1 us-gaap Nature Of Operations
NatureOfOperations
<p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">1. GENERAL</b></p><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;"><b style="font-variant:small-caps;font-weight:bold;">Certain Definitions</b></p><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;"><span style="font-family:'Times New Roman Bold';font-variant:small-caps;font-weight:bold;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-indent:36pt;margin:0pt;">For convenience in this report, the terms “Company,” “Huntsman,” “our,” “us” or “we” may be used to refer to Huntsman Corporation and, unless the context otherwise requires, its subsidiaries and predecessors. In this report, “Huntsman International” refers to Huntsman International LLC (our wholly-owned subsidiary). </p><p style="font-family:'Times New Roman';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="font-family:'Times New Roman Bold';font-variant:small-caps;font-weight:bold;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-indent:36pt;margin:0pt;">In this report, we may use, without definition, the common names of competitors or other industry participants. We may also use the common names or abbreviations for certain chemicals or products.</p><p style="font-family:'Times New Roman';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="font-family:'Times New Roman Bold';font-variant:small-caps;font-weight:bold;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;"><b style="font-variant:small-caps;font-weight:bold;">Interim Financial Statements</b></p><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;"><span style="font-family:'Times New Roman Bold';font-variant:small-caps;font-weight:bold;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-indent:36pt;margin:0pt;">Our unaudited interim condensed consolidated financial statements and Huntsman International’s unaudited interim condensed consolidated financial statements were prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP” or “U.S. GAAP”) and in management’s opinion reflect all adjustments, consisting only of normal recurring adjustments, necessary for a fair presentation of results of operations, comprehensive income, financial position and cash flows for the periods presented. Results for interim periods are not necessarily indicative of those to be expected for the full year. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes to consolidated financial statements included in the Annual Report on Form 10-K for the year ended December 31, 2019 for our Company and Huntsman International.</p><p style="font-family:'Times New Roman';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;"><b style="font-variant:small-caps;font-weight:bold;">Description of Businesses</b></p><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;"><span style="font-family:'Times New Roman Bold';font-variant:small-caps;font-weight:bold;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-indent:36pt;margin:0pt;">We are a global manufacturer of differentiated organic chemical products. We operate in four segments: Polyurethanes, Performance Products, Advanced Materials and Textile Effects. Our products comprise a broad range of chemicals and formulations, which we market globally to a diversified group of consumer and industrial customers. Our products are used in a wide range of applications, including those in the adhesives, aerospace, automotive, construction products, durable and non-durable consumer products, digital inks, electronics, insulation medical, packaging, coatings and construction, power generation, refining, synthetic fiber, textile chemicals and dyes industries. We are a leading global producer in many of our key product lines, including MDI, amines, maleic anhydride, epoxy-based polymer formulations, textile chemicals and dyes.</p><p style="font-family:'Times New Roman';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-indent:36pt;margin:0pt;">We currently operate all of our businesses through Huntsman International, our wholly-owned subsidiary. Huntsman International is a Delaware limited liability company and was formed in 1999.</p><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;"><b style="font-variant:small-caps;font-weight:bold;">Huntsman Corporation and Huntsman International Financial Statements</b></p><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;"><span style="font-variant:small-caps;font-weight:bold;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-indent:36pt;margin:0pt;">Except where otherwise indicated, these notes relate to the condensed consolidated financial statements for both our Company and Huntsman International. The differences between our financial statements and Huntsman International’s financial statements relate primarily to the following:</p><p style="font-family:'Times New Roman';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-family:'Times New Roman';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;"><span style="color:#000000;font-family:'Times New Roman';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">purchase accounting recorded at our Company for the 2003 step-acquisition of Huntsman International Holdings LLC, the former parent company of Huntsman International that was merged into Huntsman International in 2005;</span></td></tr></table><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-family:'Times New Roman';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;"><span style="color:#000000;font-family:'Times New Roman';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">the different capital structures; and</span></td></tr></table><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-family:'Times New Roman';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;"><span style="color:#000000;font-family:'Times New Roman';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">a note payable from Huntsman International to us, which was repaid in full during the quarter ended March 31, 2020.</span></td></tr></table><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;"><b style="font-variant:small-caps;font-weight:bold;">Principles of Consolidation</b></p><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;"><span style="font-variant:small-caps;font-weight:bold;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-indent:36pt;margin:0pt;">Our condensed consolidated financial statements include the accounts of our wholly-owned and majority-owned subsidiaries and any variable interest entities for which we are the primary beneficiary. Intercompany accounts and transactions have been eliminated.</p><p style="font-family:'Times New Roman';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;"><b style="font-variant:small-caps;font-weight:bold;">Reclassifications</b></p><p style="font-family:'Times New Roman';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-indent:36pt;margin:0pt;">Prior periods have been recasted to record the results of operations of our chemical intermediates businesses, which includes PO/MTBE, and our surfactants businesses (collectively, our “Chemical Intermediates Businesses”) as discontinued operations. See “Note 4. Discontinued Operations and Business Dispositions—Sale of Chemical Intermediates Businesses.”</p><p style="font-family:'Times New Roman';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;"><b style="font-variant:small-caps;font-weight:bold;">Recent Developments </b></p><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;"><span style="font-family:'Times New Roman Bold';font-variant:small-caps;font-weight:bold;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Sale of Chemical Intermediates Businesses</b></p><p style="font-family:'Times New Roman';font-size:10pt;text-indent:36pt;margin:0pt;">On January 3, 2020, we completed the sale of our Chemical Intermediates Businesses to Indorama Ventures Holdings L.P. (“Indorama”) in a transaction valued at approximately $2 billion, comprising a cash purchase price of approximately $1.93 billion, which includes estimated adjustments to the purchase price for working capital, plus the transfer of approximately $72 million in net underfunded pension and other post-employment benefit liabilities. See “Note 4. Discontinued Operations and Business Dispositions—Sale of Chemical Intermediates Businesses.”</p><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Acquisition of Icynene-Lapolla</b></p><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"/>On February 20, 2020, we completed our acquisition of Icynene-Lapolla, a leading North American manufacturer and distributor of spray polyurethane foam insulation systems for residential and commercial applications (“Icynene-Lapolla Acquisition”). Huntsman acquired the business from an affiliate of FFL Partners, LLC, for $353 million, subject to customary closing adjustments, in an all-cash transaction funded from available liquidity. The acquired business is being integrated into our Polyurethanes segment. See “Note 3. Business Combinations and Acquisitions—Acquisition of Icynene-Lapolla.”</p><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Acquisition of CVC Thermoset Specialties</b></p><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;"><span style="font-variant:small-caps;font-weight:bold;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"/>On March 15, 2020, we entered into an agreement with Emerald Performance Materials LLC, which is majority owned by affiliates of American Securities LLC, to acquire CVC Thermoset Specialties, a North American specialty chemical manufacturer serving the industrial composites, adhesives and coatings markets. CVC Thermoset Specialties operates two manufacturing facilities located in Akron, Ohio and Maple Shade, New Jersey. Under the terms of the agreement, we agreed to pay $300 million, subject to customary closing adjustments, in an all-cash transaction, which we expect to fund from available liquidity. The transaction is expected to close around midyear of 2020. The acquired business is expected to be integrated into our Advanced Materials segment.</p><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;"><b style="font-variant:small-caps;font-weight:bold;">Use of Estimates</b></p><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;"><span style="font-variant:small-caps;font-weight:bold;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-indent:36pt;margin:0pt;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p><p style="font-family:'Times New Roman';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p>
CY2020Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
4
CY2020Q1 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;"><b style="font-variant:small-caps;font-weight:bold;">Reclassifications</b></p><p style="font-family:'Times New Roman';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-indent:36pt;margin:0pt;">Prior periods have been recasted to record the results of operations of our chemical intermediates businesses, which includes PO/MTBE, and our surfactants businesses (collectively, our “Chemical Intermediates Businesses”) as discontinued operations. See “Note 4. Discontinued Operations and Business Dispositions—Sale of Chemical Intermediates Businesses.”</p>
CY2020Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;"><b style="font-variant:small-caps;font-weight:bold;">Use of Estimates</b></p><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;"><span style="font-variant:small-caps;font-weight:bold;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-indent:36pt;margin:0pt;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p>
CY2020Q1 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
182000000
CY2019Q4 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
175000000
CY2020Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
44000000
CY2019Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
49000000
CY2020Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
815000000
CY2019Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
718000000
CY2020Q1 us-gaap Inventory Gross
InventoryGross
1041000000
CY2019Q4 us-gaap Inventory Gross
InventoryGross
942000000
CY2020Q1 us-gaap Inventory Lifo Reserve
InventoryLIFOReserve
33000000
CY2019Q4 us-gaap Inventory Lifo Reserve
InventoryLIFOReserve
28000000
CY2020Q1 us-gaap Inventory Net
InventoryNet
1008000000
CY2019Q4 us-gaap Inventory Net
InventoryNet
914000000
CY2020Q1 us-gaap Percentage Of Lifo Inventory
PercentageOfLIFOInventory
0.08
CY2019Q4 us-gaap Percentage Of Lifo Inventory
PercentageOfLIFOInventory
0.09
CY2020Q1 hun Total Debt Excluding Debt To Affiliates
TotalDebtExcludingDebtToAffiliates
2183000000
CY2019Q4 hun Total Debt Excluding Debt To Affiliates
TotalDebtExcludingDebtToAffiliates
2389000000
CY2020Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
134000000
CY2019Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
212000000
CY2020Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2049000000
CY2019Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2177000000
CY2020Q1 us-gaap Long Term Debt
LongTermDebt
2183000000
CY2019Q4 us-gaap Long Term Debt
LongTermDebt
2389000000
CY2020Q1 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
11000000
CY2019Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
11000000
CY2020Q1 us-gaap Derivative Notional Amount
DerivativeNotionalAmount
465000000
CY2020Q1 us-gaap Derivative Notional Amount
DerivativeNotionalAmount
511000000
CY2019Q1 us-gaap Translation Adjustment For Net Investment Hedge Increase Decrease Net Of Tax
TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax
8000000
CY2020Q1 us-gaap Translation Adjustment For Net Investment Hedge Increase Decrease Net Of Tax
TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax
8000000
CY2019Q1 hun Cash Proceeds From Forward Swap Contract From Sale Of Investment
CashProceedsFromForwardSwapContractFromSaleOfInvestment
16000000
CY2020Q1 hun Number Of Instruments Categorized As Level Three
NumberOfInstrumentsCategorizedAsLevelThree
0
CY2020Q1 us-gaap Revenue Practical Expedient Incremental Cost Of Obtaining Contract
RevenuePracticalExpedientIncrementalCostOfObtainingContract
true
CY2020Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1593000000
CY2020Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1593000000
CY2019Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1669000000
CY2019Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1669000000
CY2020Q1 us-gaap Revenue Practical Expedient Financing Component
RevenuePracticalExpedientFinancingComponent
true
CY2020Q1 us-gaap Revenue Practical Expedient Financing Component
RevenuePracticalExpedientFinancingComponent
true
CY2019Q1 us-gaap Pension And Other Postretirement Benefit Contributions
PensionAndOtherPostretirementBenefitContributions
20000000
CY2020Q1 us-gaap Pension And Other Postretirement Benefit Contributions
PensionAndOtherPostretirementBenefitContributions
20000000
CY2020Q1 us-gaap Defined Benefit Plan Expected Future Employer Contributions Remainder Of Fiscal Year
DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear
67000000
CY2020Q1 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
5364519
CY2020Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
96000000
CY2020Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
37000000
CY2019Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
39000000
CY2019Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.1625
CY2020Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.1625
CY2020Q1 us-gaap Environmental Costs Recognized Capitalized In Period
EnvironmentalCostsRecognizedCapitalizedInPeriod
6000000
CY2019Q1 us-gaap Environmental Costs Recognized Capitalized In Period
EnvironmentalCostsRecognizedCapitalizedInPeriod
7000000
CY2020Q1 us-gaap Accrual For Environmental Loss Contingencies
AccrualForEnvironmentalLossContingencies
4000000
CY2019Q4 us-gaap Accrual For Environmental Loss Contingencies
AccrualForEnvironmentalLossContingencies
4000000
CY2020Q1 us-gaap Accrued Environmental Loss Contingencies Current
AccruedEnvironmentalLossContingenciesCurrent
1000000
CY2019Q4 us-gaap Accrued Environmental Loss Contingencies Current
AccruedEnvironmentalLossContingenciesCurrent
1000000
CY2020Q1 us-gaap Accrued Environmental Loss Contingencies Noncurrent
AccruedEnvironmentalLossContingenciesNoncurrent
3000000
CY2019Q4 us-gaap Accrued Environmental Loss Contingencies Noncurrent
AccruedEnvironmentalLossContingenciesNoncurrent
3000000
CY2020Q1 hun Maximum Period For Payment Of Remediation Liabilities
MaximumPeriodForPaymentOfRemediationLiabilities
P30Y
CY2020Q1 hun Site Contingency Number Of Former Facility Or Third Party Sites With Claims Against Entity For Cleanup Liabilities
SiteContingencyNumberOfFormerFacilityOrThirdPartySitesWithClaimsAgainstEntityForCleanupLiabilities
9
CY2020Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7000000
CY2019Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
8000000
CY2020Q1 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
1000000
CY2019Q1 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
5000000
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7000000
CY2019Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
45000000
CY2020Q1 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-72000000
CY2019Q1 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
96000000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
705000000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
119000000
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
223200000
CY2019Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
233100000
CY2019Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
2000000.0
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
223200000
CY2019Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
235100000
CY2020Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
4
CY2020Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1593000000
CY2019Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1669000000
CY2020Q1 hun Income Loss From Operations Before Interest Tax Depreciation And Amortization Net
IncomeLossFromOperationsBeforeInterestTaxDepreciationAndAmortizationNet
165000000
CY2019Q1 hun Income Loss From Operations Before Interest Tax Depreciation And Amortization Net
IncomeLossFromOperationsBeforeInterestTaxDepreciationAndAmortizationNet
204000000
CY2020Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-18000000
CY2019Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-30000000
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7000000
CY2019Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
45000000
CY2020Q1 us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
238000000
CY2019Q1 us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
5000000
CY2020Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
67000000
CY2019Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
67000000
CY2019Q1 us-gaap Depreciation And Amortization Discontinued Operations
DepreciationAndAmortizationDiscontinuedOperations
23000000
CY2020Q1 hun Segment Reconciliation Net Income Loss Attributable To Noncontrolling Interest
SegmentReconciliationNetIncomeLossAttributableToNoncontrollingInterest
3000000
CY2019Q1 hun Segment Reconciliation Net Income Loss Attributable To Noncontrolling Interest
SegmentReconciliationNetIncomeLossAttributableToNoncontrollingInterest
12000000
CY2020Q1 hun Business Combination Acquisition And Integration Related Costs
BusinessCombinationAcquisitionAndIntegrationRelatedCosts
13000000
CY2019Q1 hun Business Combination Acquisition And Integration Related Costs
BusinessCombinationAcquisitionAndIntegrationRelatedCosts
1000000
CY2020Q1 hun Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Before Income Tax Depreciation And Amortization
DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTaxDepreciationAndAmortization
1015000000
CY2019Q1 hun Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Before Income Tax Depreciation And Amortization
DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTaxDepreciationAndAmortization
51000000
CY2020Q1 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-110000000
CY2019Q1 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
76000000
CY2019Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-23000000
CY2020Q1 hun Litigation Settlements And Related Income
LitigationSettlementsAndRelatedIncome
2000000
CY2020Q1 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
2000000
CY2020Q1 hun Information Technology Project Implementation Costs
InformationTechnologyProjectImplementationCosts
1000000
CY2020Q1 us-gaap Defined Benefit Plan Amortization Of Gains Losses
DefinedBenefitPlanAmortizationOfGainsLosses
-18000000
CY2019Q1 us-gaap Defined Benefit Plan Amortization Of Gains Losses
DefinedBenefitPlanAmortizationOfGainsLosses
-17000000
CY2020Q1 hun Restructuring Impairment Plant Closing And Transition Costs
RestructuringImpairmentPlantClosingAndTransitionCosts
3000000
CY2019Q1 hun Restructuring Impairment Plant Closing And Transition Costs
RestructuringImpairmentPlantClosingAndTransitionCosts
1000000
CY2020Q1 us-gaap Profit Loss
ProfitLoss
708000000
CY2019Q1 us-gaap Profit Loss
ProfitLoss
131000000

Files In Submission

Name View Source Status
0001558370-20-004917-index-headers.html Edgar Link pending
0001558370-20-004917-index.html Edgar Link pending
0001558370-20-004917.txt Edgar Link pending
0001558370-20-004917-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
hun-20200331xex31d1.htm Edgar Link pending
hun-20200331xex31d2.htm Edgar Link pending
hun-20200331xex32d1.htm Edgar Link pending
hun-20200331xex32d2.htm Edgar Link pending
hun-20200501.xsd Edgar Link pending
hun-20200501x10q.htm Edgar Link pending
hun-20200501x10q_htm.xml Edgar Link completed
hun-20200501_cal.xml Edgar Link unprocessable
hun-20200501_def.xml Edgar Link unprocessable
hun-20200501_lab.xml Edgar Link unprocessable
hun-20200501_pre.xml Edgar Link unprocessable
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending